Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
REMICADE Trockensub 100 mg Durchstf
Drug
Remicade, Lyophilisat
Rheumatoide Arthritis; Psoriatische Arthritis; Morbus Crohn; Morbus Bechterew; aktive ulcerative Colitis; Plaque-Psoriasis
07.15.0. – immunosuppressants
HAM – Human medicine
LSPA – Parenteral solution
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
12/21/1999
12/31/9999
Dosage strength
Remicade, Lyophilisat
Rheumatoide Arthritis; Psoriatische Arthritis; Morbus Crohn; Morbus Bechterew; aktive ulcerative Colitis; Plaque-Psoriasis
01
Z – approved
Package
7680551840015
In trade from / since 12/21/1999
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component Freeze-dried preparation
100 mg infliximabum
natrii dihydrogenophosphas monohydricus
dinatrii phosphas dihydricus
saccharum
polysorbatum 80
1.943 mg natrium
dinatrii phosphas dihydricus
saccharum
polysorbatum 80
1.943 mg natrium
Spezialitätenliste***
SL
-
-
565.50
None
Yes
10%
No
Authorisation holder
7601001000902
Janssen-Cilag AG
Gubelstrasse 34
6300 Zug (ZG)
Gubelstrasse 34
6300 Zug (ZG)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.